Yishan Li Receives Stock Award at BlossomHill Therapeutics Inc (BLSM) — SEC Form 4, Aug 10, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
3.97M sh
2,134,242 → 3,973,138
Equity Change
+86.2%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Yishan Li CIK 0001772233 |
Director
Chair
10% Owner
|
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1F2 | 2026-08-10 | C - Conversion | 1,600,682 A | — | 1,600,682 | Indirect By The Li and Cui Family Trust | |
| Common StockF1F2 | 2026-08-10 | C - Conversion | 113,435 A | — | 1,714,117 | Indirect By The Li and Cui Family Trust | |
| Common StockF1F3 | 2026-08-10 | C - Conversion | 124,779 A | — | 124,779 | Indirect By RongShan, LLC |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $16.00 | 2026-08-06 | A - Award/Grant | 112,701 A | $0.00 | 2036-08-05 | 112,701 Common Stock | Direct |
| Series Angel Preferred StockF1F1F1F1F2 | 2026-08-10 | C - Conversion | 1,600,682 D | 1,600,682 Common Stock | Indirect By The Li and Cui Family Trust | |||
| Series B Preferred StockF1F1F1F1F2 | 2026-08-10 | C - Conversion | 113,435 D | 113,435 Common Stock | Indirect By The Li and Cui Family Trust | |||
| Series B Preferred StockF1F1F1F1F3 | 2026-08-10 | C - Conversion | 124,779 D | 124,779 Common Stock | Indirect By RongShan, LLC |
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Common Stock | 1,067,121 | Direct |
| Common Stock | 1,067,121 | Indirect By Spouse |
Footnotes (4)
- F1
- Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the "Preferred Stock") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date. Show more
- F2
- The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of The Li and Cui Family Trust (the "Trust") and have voting and dispositive power over the securities held by the Trust. Show more
- F3
- The Reporting Person is manager of RongShan, LLC and may be deemed to have voting and dispositive power over the securities held by RongShan.LLC. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Show more
- F4
- 1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months. Show more
Related filings at BlossomHill Therapeutics Inc
5%+ Holders · 13D/G
4 filers
Other insiders at BlossomHill Therapeutics Inc
GET /v1/forms/4/0001772233-26-000005
API docs
View Original SEC Filing